Re‐challenging chemotherapy after pembrolizumab in platinum‐refractory urothelial carcinoma
Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Yusuke Yano(Osaka University of Pharmaceutical Sciences), Wataru Fukuokaya(Jikei University School of Medicine), Keita Nakamori(Osaka University of Pharmaceutical Sciences), Jun Miki(Jikei University School of Medicine), Keiichiro Mori(Jikei University School of Medicine), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Kyosuke Nishio(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Kiyoshi Takahara(Osaka Medical and Pharmaceutical University), Ko Nakamura, Shutaro Yamamoto, Yoshio Ohno(Tokyo Medical University), Teruo Inamoto(Hamamatsu University), Takeshi Hashimoto(Tokyo Medical University), Kazumasa Komura(Kawasaki Medical School), Ryoichi Shiroki(Fujita Health University), Takahiro Kimura(Jikei University School of Medicine), Shin Egawa, Tatsuo Fukushima(Osaka University of Pharmaceutical Sciences), Shunsuke Tsuduki(Jikei University School of Medicine), Takahiro Adachi(Tokyo Medical University), Atsuhiko Yoshizawa(Fujita Health University Hospital)
Cited by 10
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
|Proceedings of the National Academy of Sciences|1996|167
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.
|Journal of Clinical Investigation|1998|127